Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 20/20 | 0.73 |
| ▸ | PPARA | Q07869 | 6/20 | 0.73 |
| ▸ | PPARG | P37231 | 3/20 | 0.73 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13811357 | 0.91 | PPARD (0.60) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL11950416 | 0.88 | PPARD (0.81) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6234941 | 0.87 | PPARD (0.82) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL17471271 | 0.87 | PPARD (0.82) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6240538 | 0.87 | PPARD (0.73) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6238031 | 0.87 | PPARD (0.81) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL4806106 | 0.87 | PPARD (0.78) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL13801306 | 0.87 | PPARD (0.78) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL6234553 | 0.87 | PPARD (0.78) | PPARDPPARAPPARGMEN1ALDH1A1 | |
| SCHEMBL5509274 | 0.86 | PPARD (0.77) | PPARDPPARAPPARGMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090163481-A1 | PPAR-DELTA LIGANDS AND METHODS OF THEIR USE | SRI INTERNATIONAL | 2009-06-25 | — | — | US | disclosed |
| US-20090163481-A1 | PPAR-DELTA LIGANDS AND METHODS OF THEIR USE | SRI INTERNATIONAL | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163481-A1 | PPAR-DELTA LIGANDS AND METHODS OF THEIR USE | PPARD, PPARG, PPARA | PPARD 1/4885PPARA 3/4885PPARG 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.